Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

Related Keywords

United Kingdom ,London ,City Of ,Newcastle Upon Tyne ,Adanna Alexander ,Nigel Mccracken ,Cameron Shaw ,Bergenbio As ,Pricewaterhousecoopers Pw ,Virax Biolabs ,James Foster ,Mark Ternouth ,Nic Johnson ,John Lewis Partnership ,Kings College London ,Strathclyde University ,Prnewswire Virax Biolabs Group Limited ,Company Contact ,Ministry Of Justice ,Company Nasdaq ,Virax Biolabs Group ,Russo Partners ,United Kingdom Home Office ,University Of Newcastle Upon Tyne ,Nasdaq ,Abbott Laboratories ,Biolabs Group Limited ,Chief Operating Officer ,Advisory Board ,Chief Executive Officer ,Chief Scientific Officer ,Bergenbio Asa ,Clinical Pharmacology ,Biochemical Toxicology ,Chief Technology Officer ,Home Office ,Virax Biolabs Group Limited ,T Cell Test ,Concerning Forward Looking Statements ,Annual Report ,Investor Contact ,Infection Control ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Personnel Announcements ,